Â鶹´«Ã½

Christian E. Elling heads the early stage biotech investment unit Â鶹´«Ã½ BioCapital. 
Christian E. Elling joined the Lundbeck Foundation in 2012 and heads the early-stage biotech investment unit Â鶹´«Ã½ BioCapital. He received his M.Sc. in Biochemistry and his Ph.D. in Pharmacology from the University of Copenhagen, Denmark. Christian was previously co-founder, Vice President of Biology and Development, and later CEO of 7TM Pharma. 

Member of the board of directors: NMD Pharma, SNIPR Biome

Former member of the board of directors: Cytoki, IO Biotech, AFYX Therapeutics, EpiTherapeutics, Inagen